← Leaderboards
Sanju Narayanan
Research Triangle Institute
$765,447
Attributed
$765,447
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $547.8K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$765,447 · 2
By mechanism
R21$547,846 · 1
R03$217,601 · 1
Top collaborators
No co-investigators on record.
Most similar at Research Triangle Institute
Same institution · by research overlap
- Yanan Zhang$8,086,410
Others in their field
Other Emerging Leaders on “Exhibits”
- John E West · University Of Texas At Austin$94,000,000
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$44,740,553
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$11,832,144
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Ashok Kumar Krishnamurthy · Univ Of North Carolina Chapel Hill$10,798,287
Research focus
ExhibitsFrequenciesDemyelinating DiseasesEvaluationDisease ProgressionExperimental Autoimmune EncephalomyelitisAnalogAblationDesignEnsureAgonistBrainCell Differentiation ProcessAxonal DegenerationChemistryChronicCollaborationsBiologyAdverse EffectsDendritesDemyelinationsDrug DiscoveryAutoimmuneGpr17 Gene
Grant awards (3)
Optimization and Characterization of Small Molecule GPR17 Antagonists for Multiple Sclerosis$547,846
R21 · FY2025 · NS · contact PI
Optimization of Small Molecule GPR17 Antagonists for Multiple Sclerosis$109,651
R03 · FY2022 · NS · contact PI
Optimization of Small Molecule GPR17 Antagonists for Multiple Sclerosis$107,950
R03 · FY2021 · NS · contact PI